A randomized controlled trial of Japanese patients with obsessive–compulsive disorder—effectiveness of behavior therapy and fluvoxamine
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background: The aim of this study was to confirm and compare the efficacy of fluvoxamine (the only licensed SSRI for treatment for OCD in Japan) and behavior therapy in treating Japanese patients with OCD. In addition, we investigated predictors of these treatments. Methods: Thirty-one outpatients meeting the DSM-III-R criteria for OCD without any axis I disorder were randomly assigned to one of three treatment conditions: BT (behavior therapy ± pill placebo), FLV [autogenic training (a psychological placebo for OCD) ± fluvoxamine] and control group [autogenic training (psychological placebo) ± pill placebo] for 12 weeks of treatment. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Clinical Global Impression-Improvement Scale (CGI-I) were administered blindly at baseline and week 4, 8 and 12. Results: Twenty-eight patients completed this study. Patients in the BT and FLV groups showed significantly more improvement than those in the control group in the mean score of total Y-BOCS; moreover, the BT group showed significantly more reduction in total Y-BOCS score at the end of treatment than the FLV group (BT > FLV, p < 0.01). Patients with lower baseline total Y-BOCS, past history of a major depressive episode and absence of cleaning compulsion improved more with fluvoxamine. Conclusions: We confirmed the effectiveness of behavior therapy and fluvoxamine for Japanese patients with OCD. Behavior therapy improved the condition of OCD patients more than fluvoxamine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stress Management was less efficacious than ERP when combined with pill placebo in a study in Japan (Nakatani et al., 2005), and less efficacious than ERP when added to ongoing medication treatment in patients who had shown partial response (Simpson et al., 2008b), and when added to substance abuse treatment in a therapeutic community for patients with comorbid substance use disorders (Fals-Stewar”
From An update on the efficacy of psychological treatments for obsessive-compulsive disorder in adults (2013) · cites this paper as Nakatani et al., 2005
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
(1976) · Medical Entomology and Zoology · Cited by 8,899
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982 · cited 1×
“were used as the principal measures. ‘Responders’ were defined as patients who showed at least 35p reduction from baseline total Y-BOCS score and were assessed as ‘much improved’ or ‘very much improved’ according to the CGI-I. Other treatment procedures were added to the regimen of ‘nonresponders’ and treatment was co…”
MethodThe Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency
Kim, S. W., Dysken, M. W., Pheley, A. M., & Hoover, K. M. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90039-6 · Cited by 2,359
Mataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716
Mataix-Cols, D., Marks, I. M., Greist, J. H., Kobak, K. A., & Baer, L. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000064812 · Cited by 499
A Review of the Efficacy of Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder
Pigott, T. A., & Seay, S. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0206 · Cited by 454
Franklin, M. E., Abramowitz, J. S., Kozak, M. J., Levitt, J. T., & Foa, E. B. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.594 · Cited by 387 · cited 1×
“On the other hand, the treatment outcome of behavior therapy in general has been satisfactory when applied appropriately [”
BackgroundGoodman, W. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180077011 · Cited by 311
Failure in treating obsessive–compulsives
Foa, E. B. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90031-7 · Cited by 305
Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review
Piccinelli, M., Pini, S., Bellantuono, C., & Wilkinson, G. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.4.424 · Cited by 282
Hohagen, F., Winkelmann, G., Rasche-Räuchle, H., Hand, I., König, A., Münchau, N., Hiss, H., Geiger-Kabisch, C., Käppler, C., Schramm, P., et al. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297924 · Cited by 280
Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis
Kobak, K. A., Greist, J. H., Jefferson, J. W., Katzelnick, D. J., & Henk, H. J. (1998) · Psychopharmacology · doi:10.1007/s002130050558 · Cited by 276
VAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199808000-00007 · Cited by 250
Controlled trial of exposure and response prevention in obsessive–compulsive disorder
Lindsay, M., Crino, R., & Andrews, G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.2.135 · Cited by 245
Foa, E. B., Franklin, M. E., & Moser, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01552-4 · Cited by 219
Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder
Ackerman, D. L., & Greenland, S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00012 · Cited by 202
Baer, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110026003 · Cited by 189
Effects of comorbid depression on response to treatment for obsessive-compulsive disorder
Abramowitz, J. S., Franklin, M. E., Street, G. P., Kozak, M. J., & Foa, E. B. (2000) · Behavior Therapy · doi:10.1016/s0005-7894(00)80028-3 · Cited by 188
Predictors of drug treatment response in obsessive-compulsive disorder.
Ravizza, L., Barzega, G., Bellino, S., Bogetto, F., & Maina, G. (1995) · PubMed · Cited by 182
Current status of pharmacological and behavioral treatment of obsessive-compulsive disorder
Stanley, M. A., & Turner, S. M. (1995) · Behavior Therapy · doi:10.1016/s0005-7894(05)80089-9 · Cited by 172
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1209 · Cited by 164
Cognitive-behavioral group therapy in obsessive–compulsive disorder: a randomized clinical trial
Volpato Cordioli, A., Heldt, E., Braga Bochi, D., Margis, R., Basso de Sousa, M., Fonseca Tonello, J., Gus Manfro, G., & Kapczinski, F. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000070785 · Cited by 158 · cited 1×
“Although obsessive-compulsive disorder (OCD) was previously considered to be refractory to most types of therapeutic intervention, there is now ample evidence that serotonin reuptake inhibitors (SRIs) and behavior therapy are highly effective methods for treatment of OCD [”
Effects of behavior therapy on regional cerebral blood flow in obsessive–compulsive disorder
Nakatani, E., Nakgawa, A., Ohara, Y., Goto, S., Uozumi, N., Iwakiri, M., Yamamoto, Y., Motomura, K., Iikura, Y., & Yamagami, T. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(03)00069-6 · Cited by 150
Self-citationReview of behavioral psychotherapy, I: Obsessive-compulsive disorders
(1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.5.584 · Cited by 139
Freeman, C. P. L., Trimble, M., Deakin, J. F. W., Stokes, T., & Ashford, J. J. (1994) · PubMed · Cited by 125
Treatment of severe obsessive-compulsive disorder with fluvoxamine
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.8.1059 · Cited by 118
Hollander, E., Koran, L. M., Goodman, W. K., Greist, J. H., Ninan, P. T., Yang, H., Li, D., & Barbato, L. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0604 · Cited by 103
McGee, M. D. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0106e · Cited by 97
A Predictive Study of Obsessive-Compulsive Disorder Response to Clomipramine
ALARCON, R. D., LIBB, J. W., & SPITLER, D. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199306000-00010 · Cited by 91
Brain-imaging approaches in psychiatry: early developmental considerations.
Price, L. H., Charney, D. S., Delgado, P. L., Goodman, W. K., Krystal, J. H., Woods, S. W., & Heninger, G. R. (1990) · PubMed · Cited by 81
Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.
Goodman, W. K., Ward, H. E., Kablinger, A. S., & Murphy, T. K. (1997) · PubMed · Cited by 63
An update on obsessive-compulsive disorder
Jenike, M. A. (2001) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.65.1.4.18714 · Cited by 54
Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment.
Greist, J. H. (1990) · PubMed · Cited by 50
Obsessive‐compulsive disorder: prediction of outcome from behavioural psychotherapy
Castle, D. J., Deale, A., Marks, I. M., Cutts, F., Chadhoury, Y., & Stewart, A. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01535.x · Cited by 30
An integrative approach to the treatment of obsessive-compulsive disorder
Foster, P. S., & Eisler, R. M. (2001) · Comprehensive Psychiatry · doi:10.1053/comp.2001.19757 · Cited by 14
Research works printed but not linked: 1
- 10.1037%2F%2F0022-006X.68.4.594 · doi:10.1037//0022-006x.68.4.594 · Paper page
Cited by
Abramowitz, J. S., Taylor, S., & McKay, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60240-3 · Cited by 1,002
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Öst, L.-G., Havnen, A., Hansen, B., & Kvale, G. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.06.003 · Cited by 655
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013) · World Psychiatry · doi:10.1002/wps.20038 · Cited by 540
Psychological treatment of obsessive–compulsive disorder: A meta-analysis
Rosa-Alcázar, A. I., Sánchez-Meca, J., Gómez-Conesa, A., & Marín-Martínez, F. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.07.001 · Cited by 444
Metadata
- Authors
- Nakatani, E., Nakagawa, A., Nakao, T., Yoshizato, C., Nabeyama, M., Kudo, A., Isomura, K., Kato, N., Yoshioka, K., & Kawamoto, M.
- Affiliations
- Kyushu University (JP)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 74
- Issue
- 5
- Pages
- 269-276
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2033378077
- Cited by
- 102
- References
- 38
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 8 · 2012: 6
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- obsessive-compulsive disorder, fluvoxamine, behavior therapy, autogenic training, selective serotonin reuptake inhibitors, predictors of treatment response, Japanese patients, treatment efficacy comparison
- MeSH terms
- Adolescent, Adult, Behavior Therapy, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Fluvoxamine, Selective Serotonin Reuptake Inhibitors, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.